TrialAdvances in therapy2024

Matching-Adjusted Indirect Comparison of Recombinant Factor IX Albumin Fusion Protein Versus Recombinant Factor IX Fc Fusion Protein for Weekly Prophylactic Treatment of Hemophilia B.

Benoit Guillet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.